LC-MS/MS Coupled with Stable Isotope Dilution Method for the Quantification of 6-Thioguanine and S6-Methylthioguanine in Genomic DNA of Human Cancer Cells Treated with 6-Thioguanine
Authors:
- 15 June 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 82 (13) , 5797-5803
Abstract
Thiopurines, including mercaptopurine (MP), 6-thioguanine (SG) and azathioprine, are widely used for the treatment of many human diseases including acute lymphoblastic leukemia (ALL). To exert their cytotoxic effect, these prodrugs need to be metabolically activated to SG nucleotides and incorporated into nucleic acids. SG in DNA can be methylated spontaneously to S6-methylthioguanine (S6mG) in the presence of S-adenosyl-l-methionine. It was proposed that S6mG, owing to its high miscoding potential (pairing preferentially with thymine), may induce cell death by triggering the postreplicative mismatch repair pathway. Understanding the implications of this pathway in the cytotoxic effect of thiopurine drugs necessitates an accurate measurement of the level of S6-methylthio-2′-deoxyguanosine (S6mdG) in DNA of cells treated with thiopurine drugs. Here we developed a sensitive HPLC coupled with tandem mass spectrometry (LC-MS/MS) method and measured the level of 6-thio-2′-deoxyguanosine (SdG) and S6mdG in genomic DNA of four human leukemia cell lines and one human colorectal carcinoma cell line. Our results revealed that, upon treatment with 3 μM SG for 24 h, approximately 10, 7.4, 7, and 3% of guanine was replaced with SG in Jurkat T, HL-60, CCRF-CEM and K-562 cells, respectively. However, only less than 0.02% of SdG was converted to S6mdG in the above cell lines. HCT-116 cells had the lowest level (0.2%) of guanine being replaced with SG in DNA, and approximately 5 out of 104 SG was converted to its methylated counterpart. This is the first report of the simultaneous and accurate quantification of SdG and S6mdG in genomic DNA of cultured human cells treated with SG. In addition, our results suggested that DNA SG might trigger mismatch repair (MMR) pathway without being converted to S6mG.Keywords
This publication has 29 references indexed in Scilit:
- 6-Thioguanine Perturbs Cytosine Methylation at the CpG Dinucleotide Site by DNA Methyltransferasesin Vitroand Acts as a DNA Demethylating Agentin VivoBiochemistry, 2009
- Mutagenic and Cytotoxic Properties of 6-Thioguanine, S-Methylthioguanine, and Guanine-S6-sulfonic AcidJournal of Biological Chemistry, 2008
- Azathioprine and UVA Light Generate Mutagenic Oxidative DNA DamageScience, 2005
- Cytotoxic Mechanism of 6-Thioguanine: hMutSα, the Human Mismatch Binding Heterodimer, Binds to DNA Containing S6-MethylthioguanineBiochemistry, 1997
- Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanismsPharmacogenetics, 1996
- DNA Mismatch Binding and Incision at Modified Guanine Bases by Extracts of Mammalian Cells: Implications for Tolerance to DNA Methylation DamageBiochemistry, 1994
- Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipientThe Lancet, 1993
- Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemiaThe Journal of Pediatrics, 1991
- Molecular dosimetry of sister chromatid exchange induction in 9L cells treated with 6-thioguanineMutagenesis, 1991
- Differential chromatid damage induced by 6-thioguanine in CHO cellsExperimental Cell Research, 1981